Events

Overview

Place: FHNW School of Life Sciences (Auditorium), Hofackerstrasse 30, 4132 Muttenz

Anke Hollnagel

Your contact person

Anke Hollnagel

PhD | Director Asia


Tel. +41 61 295 50 10

anke.notexisting@nodomain.comhollnagel@baselarea.notexisting@nodomain.comswiss
event

24.10.2019

Swiss-Chinese Life Sciences Forum 2019

Basel and China look back on a many years of mutual exchange in the field of Life Sciences. Basel-based pharma companies have invested heavily in China ever since the Chinese economy started to open up. Recently, we can also observe an increased interest of Chinese companies to invest in Basel. China's Luye Pharma and BeiGene both established their European headquarters in Switzerland recently. ChemChina acquired Syngenta in 2017.
 
The Swiss-Chinese Life Sciences Forum takes place for the third time on October 24, 2019 in Basel in the new auditorium of the School of Life Sciences FHNW. This event has successfully fostered the relationship between Life Sciences communities in Switzerland and China in the past two years and continues to be the key Sino-Swiss life sciences event.
 
The future of healthcare will be world dominated by data and controlled by individual patients. How do we get there? What has already been done? What are the most promising applications and what are the biggest challenges? How do we meet the growing demand for digital health talents? How is the industry affected by new players from non-healthcare technology fields? How to make health data useful and applicable (standardization, etc.)? How can personal information be protected?
MC & Moderation: Tanya König, Journalist at CNNMoney Switzerland
 
When: 24.10.2019, 13:30 - 18:30
Where: FHNW School of Life Sciences (Auditorium), Hofackerstrasse 30, 4132 Muttenz

 
Programm Details

13:30

Registration

14:00

Welcome
Dr. Beat Krähenmann, Prof. Schlottig

14:15

1. Key Note Speaker
Christian Hein, Executive Director of Digital Strategy at Novartis

14:35

2. Key Note: Pearls from SHELL- digital healthcare on chronic disease management to digital clinical trial management
Jessica Liu, VP, Head of International Business, Tigermed Co. Ltd

14:55

3. Key Note Speaker
Prof. Dr. Jörg Goldhahn, ETH Zürich, Head of Department of Health Sciences and Technology, Vice Director of Institute for Translational Medicine

15:15

4. Key Note Speaker
Oksana Avdeeva, EY-Parthenon

15:35

Break

15:55

Panel Discussion
moderated by Tanya König, Journalist at CNNMoney Switzerland

16:55

Closing

17:05

Apéro

 
Please register here.
 
fee
80 CHF Members
120 CHF Non-members
 
Co-Organizers:
Fachhochschule Nordwestschweiz
Swiss Chinese Chamber of Commerce
 
 
 

 

Cookies

BaselArea.swiss uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.

Ok